SMU Medical Journal

Open Access Open Access  Restricted Access Subscription Access

Ebola Virus Vaccines


Affiliations
1 Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, India
 

Ebola hemorrhagic fever, an extremely fatal viral disease is caused by Ebola virus. The African subcontinent is experiencing the most fatal epidemic caused by this virus. Recently, a few cases have been detected outside Africa. Thus, this is of concern and has alerted World Health Organization (WHO). Currently there is no cure for Ebola, nor is there a vaccine approved yet for human use. A few vaccines are under clinical trials. Thus, there needs to be an integrated approach in prevention of this fatal disease by an effective vaccine formation.
User
Notifications
Font Size

Abstract Views: 231

PDF Views: 121




  • Ebola Virus Vaccines

Abstract Views: 231  |  PDF Views: 121

Authors

Nitya Batra
Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, India
Satish Gupte
Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, India
Prerna Aggarwal
Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, India
Maninder Kaur
Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, India
Ashwini Manhas
Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, India
Manju Bala
Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, India
Ravi Kumar
Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, India

Abstract


Ebola hemorrhagic fever, an extremely fatal viral disease is caused by Ebola virus. The African subcontinent is experiencing the most fatal epidemic caused by this virus. Recently, a few cases have been detected outside Africa. Thus, this is of concern and has alerted World Health Organization (WHO). Currently there is no cure for Ebola, nor is there a vaccine approved yet for human use. A few vaccines are under clinical trials. Thus, there needs to be an integrated approach in prevention of this fatal disease by an effective vaccine formation.